Get your company's press releases published in the world's most…

Get your company's press releases published in the world's most powerful biotechnology
publication.

GEN's editorial strength lies in the wide breadth of coverage encompassing the entire field of
biotechnology, from the latest advances in drug discovery through bioprocess scale-up and
commercial production. Biotechnology professionals rely on GEN for authoritative coverage of
biomarkers, proteomics, molecular diagnostics, cell culture, and more.

GEN welcomes your news and new product releases. We also invite companies to submit tutorials
and application notes as well as technology overview articles that serve to demonstrate your firm's
expertise and bring you new business opportunities.

Please see GEN's guidelines below for submitting news, articles, tutorials, and new product
information.

SUBMISSION GUIDELINES
Print and Online News
Send all company press releases to Querida Anderson at qanderson@genengnews.com.

Online News
News is compiled daily for GEN's online news coverage. The stories are posted everyday on our
website as well as sent out in a e-newsletter to subscribers. Coverage encompasses five core topics:
BioBusiness, OMICS, Drug Discovery, Bioprocessing, and Clinical Research and Diagnostics. In
addition, Product & Service deals are highlighted.

News Columns in Print GEN

Bioprocessing Highlights
Reports on scale-up and production: purification, cell culture, facility news, CMO agreements,
etc.

Molecular Diagnostics
Reviews deals and findings involving biotech and pharma companies: biomarker discoveries,
licensing transactions, M&A activity, collaborations for R&D, commercialization, etc.

Clinical Trials Updates
Includes Phase I through III studies in various indications
Discovery & Development Briefs
Covers the gamut of alliances formed related to preclinical and clinical R&D: target identification,
validation, IND-enabling studies, etc.

Genomics & Proteomics
Details research and partnerships: gene identification and manipulation, gene and protein
expression, protein-structure analysis, etc.

Inside Industry
Analyzes business and financial news: M&A activity, divestitures, establishment of subsidiaries,
regulatory approvals, grants and funding, etc.

Products & Service Deals
Looks at agreements among biotech, pharmaceutical, and supplier companies: technology
transfer, enabling technology deals, CRO transactions, etc.

People in the News
Lists new hires and promotions in the industry.

Additional Columns
Additional columns include: Point of View (opinions on a biotech-related issue), Legal Affairs
(authored by lawyers with biotech expertise), Wall St. Biobeat (GEN's monthly financial-themed
column), and Biomarket Trends (industry trends summarized from specialist reports).
Submission queries for these columns should be directed to Tamlyn Oliver at
toliver@genengnews.com. Finally, GEN's Calendar of Events includes conferences, trade shows,
workshops, and symposia relevant to biotech.

New Product Announcements
GEN offers biotechnology tool providers a compelling way to promote their new products. All new
product announcements should be sent to Tamlyn Oliver at toliver@genengnews.com. Please send
a full product description, company name, website, and product shot with a resolution of 300 dpi
at 5-inches wide. Submission of the high-resolution electronic image of the product is mandatory.
Logos are not accepted.

 Feature Articles
GEN's editorial calendar lists the feature articles for each issue. If you want your company
included in a particular article, please contact John Sterling at jsterling@genengnews.com three
months prior to the publication date (clearly indicating the issue and topic in the subject line of
your email message), as this is generally when articles are assigned.

Tutorials
GEN publishes Drug Discovery, Assay, Bioprocess, and Clinical Research and Diagnostic
Tutorials in every issue. We welcome queries for submissions of tutorials outlining the use of a
particular technology or application. These semitechnical articles should preferably include
numerical and/or pictographic data (four graphics maximum, including tables). Please avoid
marketing descriptions or advertorial writing; it is GEN's policy to focus on the science. This is an
opportunity to highlight the technical strengths of your company's product or service. Note that
we do not include references; tutorials are technical application notes and not data-rigorous
presentations as are peer-reviewed submissions.
As tutorials are not usually time-sensitive, GEN schedules these articles many months in advance.
You may wish to time the publication of your tutorial with a particular issue given its editorial
focus or its intended distribution. If so, please query us well in advance to ensure that a particular
slot is available. As space varies, however, inclusion in a particular issue cannot be guaranteed.
Please contact John Sterling (jsterling@genengnews.com) or Tamlyn Oliver
(toliver@genengnews.com) to pitch a tutorial idea. If your tutorial query is accepted, we will
contact you with detailed submission requirements and guidelines for submitting electronic
graphics.

Drug Discovery Tutorials cover technology related to high-throughput screening, target
identification, validation, etc., that is used to identify and develop biopharmaceutical compounds
and small molecules. Word count: 1,000 words

Assay Tutorials cover technology relating to assays for drug discovery and development, including
assessment of molecular binding, ADMET, expression, visualization techniques, etc. Word count:
1,000 words

Bioprocess Tutorials cover technology, from bioreactors to media to cell lines, relating to cell
culture, scale-up, process transfer, etc., in the production of biomaterials. Word count: 1,000
words.

Clinical Research & Diagnostics Tutorials cover clinical research and technology and methods for
the manufacture and production of molecular diagnostic products.

*Note that GEN does not solicit payment for any editorial coverage and respects all embargoes.

GEN's Planning Calendar containing the editorial focus for each issue is posted at
www.genengnews.com/media/pdf/2008GENcalendar6m.pdf

GEN distributes particular issues at international meetings and conferences. These are also listed
in the editorial calendar.

GEN Contact Information
Editorial office (914) 740-2200
Editor in Chief ­ John Sterling (jsterling@genengnews.com)
Managing Editor ­ Tamlyn Oliver (toliver@genengnews.com)
Online News Editor ­ Querida Anderson (qanderson@genengnews.com)